Most untreated subclinical hypothyroidism in pregnancy corrects itself

Design

Secondary analysis of placebo arms of two multicentre randomised trials

Population

326 women with subclinical hypothyroidism and 254 with hypothyroxinaemia identified before 20 weeks

Primary outcome

Thyroid function trajectory on monthly testing through pregnancy

Effect

Later normal result in 88.7% vs 61.4%; overt hypothyroidism in 2.5% and 2.0%

This secondary analysis used only the placebo arms of two parallel NICHD trials that had tested levothyroxine for offspring IQ. Women were identified before 20 weeks with subclinical hypothyroidism (raised TSH, normal free T4; 326 tested) or hypothyroxinaemia (normal TSH, low free T4; 254 tested), and had thyroid function checked monthly for the rest of pregnancy.

Most had at least one normal result later on: 88.7% of the subclinical hypothyroidism group and 61.4% of the hypothyroxinaemia group. Overt hypothyroidism developed in 2.5% and 2.0% respectively. Thyroid peroxidase antibody status did not predict who stayed abnormal.

This matters because the parent trials had already found no IQ benefit from treatment. The new point is that a single early abnormal result often does not persist, so early screen-and-treat strategies will treat many women whose values would normalise. It does not tell you what to do for a woman whose TSH stays raised, and it is a US population with mild abnormalities, so it does not speak to overt disease or to iodine-deficient settings.

• Repeat thyroid function before committing to levothyroxine for a single mildly raised TSH with normal free T4.
• Expect about 1 in 40 women with early subclinical hypothyroidism to become overtly hypothyroid; recheck if symptoms appear.
• Do not use a positive TPO antibody result alone to predict persistence; it did not in this cohort.
• Treat overt hypothyroidism as before; this analysis covers only mild, biochemical abnormalities.

Why it matters

Universal early screening will label many women whose thyroid results would have normalised on their own.

Don't overread it

This is a post-hoc look at placebo arms; it does not show that treating persistent abnormalities is useless.

The statistics, in plain English

These are simple proportions, not comparisons, so there are no confidence intervals to interpret. The 2.5% and 2.0% rates of overt hypothyroidism come from 8 and 5 women respectively — small numbers, so the true rate could reasonably be a little higher or lower.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.